(Q44449441)

3 December 2017

The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates (English)

1 reference

3 December 2017

0 references

1 reference

Arianna Waye

1

1 reference

3 December 2017

Philip Jacobs

series ordinal

2

1 reference

3 December 2017

Ben Tan

series ordinal

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

20 August 2013

1 reference

3 December 2017

1 reference

3 December 2017

31

1 reference

3 December 2017

4744-4748

1 reference

3 December 2017

42

1 reference

National immunization strategy. A model for resolving jurisdictional disputes in public health

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Economic evaluation of vaccination programs: the impact of herd-immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Vaccination with partial knowledge of external effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Deterministic SIR (Susceptible-Infected-Removed) models applied to varicella outbreaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Varicella among adults: data from an active surveillance project, 1995-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

The economic value of childhood varicella vaccination in France and Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Epidemiology of varicella hospitalizations in the United States, 1995-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Economic evaluations of varicella vaccination programmes: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Use of National Health Insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Decline in mortality due to varicella after implementation of varicella vaccination in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Impact of varicella vaccination on health care outcomes in Ontario, Canada: Effect of a publicly funded program?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Impact of varicella vaccination on health care utilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.022

10.1016/J.VACCINE.2013.08.022

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference